Literature DB >> 7554520

Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.

B D Schreiber1, M L Hughes, G C Groggel.   

Abstract

Diabetic nephropathy is characterized by mesangial cell proliferation and expansion of the mesangial matrix. Insulin-like growth factor-1 (IGF-1) increases in the kidney early in experimental diabetes. The effect of IGF-1 on mesangial cell proliferation and synthesis of extracellular matrix (ECM) proteins was examined to test the hypothesis that IGF-1 stimulates mesangial cells to synthesize ECM proteins. ECM proteins were measured by immunoprecipitation after metabolic labeling of rat mesangial cells in culture. IGF-1 caused a 2.4-fold increase in mesangial cell proliferation as measured by 3H-thymidine incorporation. IGF-1 caused an increase in cellular laminin, fibronectin and type IV collagen, 46.8 +/- 15.4%, 31.3 +/- 11.4%, and 27.7 +/- 12.6% increase respectively compared to control cells. IGF-1 did not effect cellular type 1 collagen, decrease of 8.2 +/- 8.7%. There was a trend toward increased total protein synthesis by IGF-1, 36.5 +/- 2.5%. In summary, IGF-1 stimulates ECM component production by mesangial cells. Thus, IGF-1 has the capacity to mediate the histologic changes characteristic of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554520

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

1.  IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells.

Authors:  David D New; Karen Block; Basant Bhandhari; Yves Gorin; Hanna E Abboud
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

Review 2.  The role of the renal kallikrein-kinin system in diabetic nephropathy.

Authors:  Alexander Riad; Jia Long Zhuo; Heinz Peter Schultheiss; Carsten Tschöpe
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-01       Impact factor: 2.894

Review 3.  Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.

Authors:  Li Gao; Xiang Zhong; Juan Jin; Jun Li; Xiao-Ming Meng
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

4.  HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice.

Authors:  Caifeng Yan; Weifeng Xu; Yujie Huang; Min Li; Yachen Shen; Hui You; Xiubin Liang
Journal:  Mol Endocrinol       Date:  2016-04-15

5.  Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury.

Authors:  Jinhua Tang; Na Liu; Evelyn Tolbert; Murugavel Ponnusamy; Li Ma; Rujun Gong; George Bayliss; Haidong Yan; Shougang Zhuang
Journal:  Am J Pathol       Date:  2013-05-15       Impact factor: 4.307

6.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.

Authors:  Lori K Davis; Buel D Rodgers; Kevin M Kelley
Journal:  Endocrine       Date:  2008-04-08       Impact factor: 3.633

7.  Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts.

Authors:  Frédéric Massicotte; Isabelle Aubry; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Julio Fernandes; Daniel Lajeunesse
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathy.

Authors:  Jin Taek Kim; Sang Soo Kim; Dae Won Jun; Young Hwan Hwang; Wook-Ha Park; Youngmi Kim Pak; Hong Kyu Lee
Journal:  J Diabetes Investig       Date:  2013-04-22       Impact factor: 4.232

Review 9.  The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.

Authors:  Youngman Oh
Journal:  Kidney Res Clin Pract       Date:  2012-01-17

10.  Identification of key genes for diabetic kidney disease using biological informatics methods.

Authors:  Fuzhe Ma; Tao Sun; Meiyan Wu; Wanning Wang; Zhonggao Xu
Journal:  Mol Med Rep       Date:  2017-09-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.